Tongling Jieya Biologic Technology Co., Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 129.64 million compared to CNY 127.8 million a year ago. Net income was CNY 13.9 million compared to CNY 37.27 million a year ago.

Basic earnings per share from continuing operations was CNY 0.17 compared to CNY 0.46 a year ago. Diluted earnings per share from continuing operations was CNY 0.17 compared to CNY 0.46 a year ago.